ADHD Trial, Recruiting NCT06632249 Sponsor: Hospital de Clinicas de Porto Alegre Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06632249
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with ADHD according to the DSM-5 diagnostic guidelines
  • People aged between 12 and 17 years old
  • People who have either never taken ADHD medication, or who have not taken ADHD medication for at least one month

Who may not be able to join:

  • People who have serious additional mental health or physical health conditions, or a history of seizures, that would prevent them from safely taking part in high-intensity exercise in a virtual reality setting
  • People whose inattention symptoms score below 12 on a standard ADHD rating scale called the SNAP-IV inattention subscale (confirm with trial site)
  • People with an IQ score below 70
  • People who already do intense, structured physical activity more than twice a week
  • People (for the MRI portion of the trial) who have certain medical devices or metal objects in their body, such as specific types of aneurysm clips, cochlear implants, pacemakers, metal fragments in the body or eyes, or piercings that cannot be removed
  • People (for the MRI portion) who have internal metal in their body that could interfere with the MRI scan images
  • People (for the MRI portion) who experience severe claustrophobia (strong fear of enclosed spaces)
  • People (for the MRI portion) who have breathing difficulties that would prevent them from cooperating during the scan
  • People (for the MRI portion) who are unable to stay still during the scan due to hyperactivity
  • People (for the MRI portion) whose body weight or size exceeds the limits of the MRI equipment
  • People (for the MRI portion) who have excessive involuntary movement
  • People (for the MRI portion) who have certain physical differences in brain or body structure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luis Augusto Rohde, PhD, Hospital de Clínicas de Porto Alegre

Phone: +55 51 33598094

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital de Clinicas de Porto Alegre
Registry
ClinicalTrials.gov
Start date
13 September 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Inattention total score; Inhibibitory Control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov